Vicky Nahra
Rheumatology · Cleveland, OHNPI 1255926762
Payments from drug & device makers
Across 17 payments — averaging $83.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- AbbVie$182
- Amgen$39
- Aurinia Pharma U.S., Inc.$25
- Kyowa Kirin, Inc.$23
- E.r. Squibb & Sons, L.L.C.$19
- plus $28 from 2 others
What the payments were for
- Travel & lodging$86162%
- Food & beverage$53638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $1,096 |
| AbbVie | 6 | $182 |
| Amgen | 2 | $39 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| AstraZeneca | 1 | $14 |
| Pfizer | 1 | $14 |
How this compares
$1,412 in reported general payments places this provider in the 45th percentile of 255 rheumatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 41 | $335,134 |
| Enbrel SureclickEtanercept | 27 | $198,168 |
| Orencia ClickjectAbatacept | 17 | $95,857 |
| ForteoTeriparatide | 13 | $53,552 |
| Actemra ActpenTocilizumab | 13 | $50,587 |
| Teriparatide | 13 | $32,086 |
| Hydroxychloroquine Sulfate | 81 | $4,489 |
| MethotrexateMethotrexate Sodium | 140 | $4,349 |
| Leflunomide | 34 | $2,874 |
| Colchicine | 29 | $1,446 |
| Prednisone | 171 | $966 |
| Sulfasalazine | 21 | $638 |
| Allopurinol | 74 | $494 |
| Alendronate Sodium | 80 | $303 |
| Celecoxib | 16 | $195 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Cleveland
- Nora SingerCleveland$3M
- Leonard CalabreseCleveland$1.9M
- Carol LangfordCleveland$1.8M
- M Elaine HusniCleveland$680K
- Chad DealCleveland$420K
- Muhammad KhanCleveland$262K
- Adam BrownCleveland$247K
- Brian MandellCleveland$166K
- Stanley BallouCleveland$154K
- Soumya ChatterjeeCleveland$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.